Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AZD9574 |
| Trade Name | |
| Synonyms | AZD-9574|AZD 9574 |
| Drug Descriptions |
AZD9574 is a PARP1 inhibitor that can penetrate the blood-brain barrier, potentially leading to inhibition of tumor growth (PMID: 37967136). |
| DrugClasses | PARP-1 Inhibitor 13 |
| CAS Registry Number | 2756333-39-6 |
| NCIT ID | C188237 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AZD0516 + AZD9574 | AZD0516 AZD9574 | 0 | 1 |
| AZD2936 + AZD8205 + AZD9574 | AZD2936 AZD8205 AZD9574 | 0 | 1 |
| AZD8205 + AZD9574 | AZD8205 AZD9574 | 0 | 1 |
| AZD9574 | AZD9574 | 0 | 1 |
| AZD9574 + Datopotamab deruxtecan | AZD9574 Datopotamab deruxtecan | 0 | 1 |
| AZD9574 + Temozolomide | AZD9574 Temozolomide | 0 | 1 |
| AZD9574 + Trastuzumab deruxtecan | AZD9574 Trastuzumab deruxtecan | 0 | 1 |